Analysts’ Top Healthcare Picks: Dynavax (DVAX), Idera (IDRA)

By Jason Carr

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dynavax (DVAXResearch Report) and Idera (IDRAResearch Report) with bullish sentiments.

Dynavax (DVAX)

In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Dynavax, with a price target of $13.00. The company’s shares closed last Monday at $5.23.

According to TipRanks.com, White is a 5-star analyst with an average return of 14.3% and a 48.8% success rate. White covers the Healthcare sector, focusing on stocks such as Spectrum Pharmaceuticals, Karyopharm Therapeutics, and TRACON Pharmaceuticals.

Currently, the analyst consensus on Dynavax is a Strong Buy with an average price target of $16.50, a 208.4% upside from current levels. In a report released yesterday, Cowen & Co. also maintained a Buy rating on the stock with a $20.00 price target.

See today’s analyst top recommended stocks >>

Idera (IDRA)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Idera, with a price target of $9.00. The company’s shares closed last Monday at $2.52, close to its 52-week low of $2.08.

According to TipRanks.com, Ramakanth has 0 stars on 0-5 star ranking scale with an average return of -9.2% and a 31.9% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Zomedica Pharmaceuticals, ThermoGenesis Holdings, and IntelGenx Technologies.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Idera with a $8.67 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.